These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1348974)

  • 1. Intrinsic resistance to anticancer agents in the murine pancreatic adenocarcinoma PANC02.
    Priebe TS; Atkinson EN; Pan BF; Nelson JA
    Cancer Chemother Pharmacol; 1992; 29(6):485-9. PubMed ID: 1348974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of resistance to 6-thioguanine in a murine pancreatic tumor.
    Pan BF; Priebe TS; Nelson JA
    Cancer Chemother Pharmacol; 1992; 29(6):471-4. PubMed ID: 1568290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.
    Lee FY; Sciandra J; Siemann DW
    Biochem Pharmacol; 1989 Nov; 38(21):3697-705. PubMed ID: 2574574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance.
    Sakata K; Kwok TT; Murphy BJ; Laderoute KR; Gordon GR; Sutherland RM
    Br J Cancer; 1991 Nov; 64(5):809-14. PubMed ID: 1681885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.
    Loor F; Boesch D; Gavériaux C; Jachez B; Pourtier-Manzanedo A; Emmer G
    Br J Cancer; 1992 Jan; 65(1):11-8. PubMed ID: 1346365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination doxorubicin and interferon-α therapy stimulates immunogenicity of murine pancreatic cancer Panc02 cells via up-regulation of NKG2D ligands and MHC class I.
    Wang WJ; Qin SH; Zhang JW; Jiang YY; Zhang JN; Zhao L
    Asian Pac J Cancer Prev; 2014; 15(22):9667-72. PubMed ID: 25520086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic aspects of multidrug resistance.
    Biedler JL
    Cancer; 1992 Sep; 70(6 Suppl):1799-809. PubMed ID: 1355404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel model system for studying the double-edged roles of nitric oxide production in pancreatic cancer growth and metastasis.
    Wang B; Wei D; Crum VE; Richardson EL; Xiong HH; Luo Y; Huang S; Abbruzzese JL; Xie K
    Oncogene; 2003 Mar; 22(12):1771-82. PubMed ID: 12660813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
    Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
    J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A syngeneic orthotopic murine model of pancreatic adenocarcinoma in the C57/BL6 mouse using the Panc02 and 6606PDA cell lines.
    Partecke LI; Sendler M; Kaeding A; Weiss FU; Mayerle J; Dummer A; Nguyen TD; Albers N; Speerforck S; Lerch MM; Heidecke CD; von Bernstorff W; Stier A
    Eur Surg Res; 2011; 47(2):98-107. PubMed ID: 21720167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
    Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel, clinically relevant animal model of metastatic pancreatic adenocarcinoma biology and therapy.
    Wang B; Shi Q; Abbruzzese JL; Xiong Q; Le X; Xie K
    Int J Pancreatol; 2001; 29(1):37-46. PubMed ID: 11558631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant expression of multiple drug resistance after in vitro X-irradiation exposure in intraspecific Chinese hamster ovary hybrid cells.
    McClean S; Hosking LK; Hill BT
    J Natl Cancer Inst; 1993 Jan; 85(1):48-53. PubMed ID: 8093217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of P-glycoprotein in dolastatin 10 resistance.
    Toppmeyer DL; Slapak CA; Croop J; Kufe DW
    Biochem Pharmacol; 1994 Aug; 48(3):609-12. PubMed ID: 7915113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model.
    Okudaira K; Hokari R; Tsuzuki Y; Okada Y; Komoto S; Watanabe C; Kurihara C; Kawaguchi A; Nagao S; Azuma M; Yagita H; Miura S
    Int J Oncol; 2009 Oct; 35(4):741-9. PubMed ID: 19724910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of adriamycin-resistant and radiation-sensitive Chinese hamster cell lines.
    Sognier MA; Zhang Y; Eberle RL; Belli JA
    Biochem Pharmacol; 1992 Nov; 44(9):1859-68. PubMed ID: 1360213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells.
    Clary BM; Coveney EC; Philip R; Blazer DG; Morse M; Gilboa E; Lyerly HK
    Cancer Gene Ther; 1997; 4(2):97-104. PubMed ID: 9080118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas.
    Hinoshita E; Uchiumi T; Taguchi K; Kinukawa N; Tsuneyoshi M; Maehara Y; Sugimachi K; Kuwano M
    Clin Cancer Res; 2000 Jun; 6(6):2401-7. PubMed ID: 10873092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas.
    Hoffmann J; Schmidt-Peter P; Hänsch W; Naundorf H; Bunge A; Becker M; Fichtner I
    Clin Cancer Res; 1999 Aug; 5(8):2198-204. PubMed ID: 10473106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.